Nitric oxide enhancement and blood pressure decrease in patients with metabolic syndrome using soy protein or fish oil

Article (PDF Available)inArquivos brasileiros de endocrinologia e metabologia 54(6):540-5 · August 2010with49 Reads
DOI: 10.1590/S0004-27302010000600005 · Source: PubMed
To verify the effects of fish oil and soy on nitric oxide (NO) and blood pressure in patients with metabolic syndrome (MS). Sixty women with MS were investigated in a parallel randomized design study. The first group maintained their usual diet; the second group received 25 g/day of soy; the third group received 3 g/day of n-3 fatty acids, and the fourth group the same amount previously cited of n-3 fatty acids and soy. Serum nitric oxide metabolites showed significant increase after 90 days in the fish oil and soy groups. Systolic pressure reduced after 45 days of treatment with fish oil, whereas diastolic pressure decreased significantly throughout the study in the soy group. NO increase and blood pressure reduction with fish oil or soy protein reinforce the importance of the influence of NO on blood pressure in patients with MS.

Full-text (PDF)

Available from: Andréa Name Colado Simão
    • "Bioactive components such as isoflavones, soy protein or unique amino acid profile (higher arginine to lysine and methionine ratio) of soy bean might be responsible for these favorable effects [37]. Enhancement of serum nitric oxide level after consumption of soy product is associated with blood pressure reduction [38] . Angiotensin converting enzyme (ACE) inhibitory peptides derived from soy bean also have a role in blood pressure reduction through their ability to limit the vasoconstrictory effects of angiotensin II and potentiate the vasodilatory effects of Bradikinin [39]. "
    [Show abstract] [Hide abstract] ABSTRACT: Recent studies suggest that inclusion of soy product in the diet may have favorable effects on relief of cardiovascular diseases (CVDs) and risk factors. These effects might be associated with the presence of specific polymorphism in gene. The aim of this study was to examine the effects of consumption of soy flour fortified bread on cardiovascular risk factors in overweight and obese women according to APOE genotype. In a randomized cross-over clinical trial 30 overweight and obese women received a mild weight loss diet and assigned to a regular diet and a soy bread diet, each for 6 weeks and a washout period for 20 days. Subjects in the soy bread diet were asked to replace 120 grams of their daily usual bread intake with equal amount of soy bread. No significant effects of soy bread on serum lipid, systolic blood pressure and anthropometric indices were observed compared to the regular diet (p > 0.05). For diastolic blood pressure (DBP), comparison of mean differences between two groups showed a marginally significant effect of soy bread (p = 0.06). Compared to regular diet, soy bread had a significant effect on DBP in E2 genotype group (ε2/ε2) (p = 0.03). Having ε2 allele may influences responses of CVD risk factor to soy bread consumption. However more nutrigenetic studies are required.
    Full-text · Article · Nov 2015
    • "Soy protein intake increases nitric oxide levels that have vasodilatory effects. High amount of arginine, nitric oxide precursor, in the amino acid profile of soy protein might explain soy protein effects on nitric oxide levels [34]. Angiotensin-converting enzyme inhibitory peptides exist in plant proteins such that soy can be enzymatically released from precursor proteins. "
    [Show abstract] [Hide abstract] ABSTRACT: Previous studies showed that soy bean has the potential to improve many aspects of diabetes state and provide metabolic benefits that aid in weight management. We aimed to determine the effects of soy bean flour enriched bread on anthropometric indices and blood pressure among type 2 diabetic patients. This randomized, crossover, clinical trial was performed in 30 type 2 diabetic women. There were two trial periods for 6 weeks and a wash-out period for 4 weeks. In the soy bread diet period, 120 g of soy bean flour enriched bread was consumed each day instead of the same amount of their usual bread or other cereal products. After a 4-week wash-out period, participants were crossed over for another 6 weeks. Mean (±SD) age of study participants was 45.7 ± 3.8 years. The results of our study showed no significant effects of soy bean flour enriched bread on anthropometric indices and blood pressure among diabetic patients. Despite the slight reduction in BMI, waist circumference, and percent of body fat, there were no significant differences in changes of these values between two groups. No significant changes in waist to hip ratio and blood pressure were seen.
    Full-text · Article · Sep 2014
    • "In human studies a low-GI diet plus a supplement of 30 g of soy protein and 4 g of phytosterols significantly decreased total cholesterol, LDL cholesterol and blood pressure compared to a standard diet [162] . In addition , a 25 g daily soy supplement has been related to an increase in NO and a significant reduction in blood pressure in patients with MetS [163]. Also, individuals with MetS treated with soybean show a decrease in fasting glucose and increase in serum HDL and adiponectin [164]. "
    [Show abstract] [Hide abstract] ABSTRACT: The metabolic syndrome (MetS) is a clustering of risk factors for the development of cardiovascular disease and type 2 diabetes mellitus. These risk factors include raised blood pressure, dyslipidemia (raised triglycerides and lowered high-density lipoprotein cholesterol), raised fasting glucose, and central obesity. MetS has become a serious public health and clinical problem whose prevalence and incidence are increasing along with the worldwide rise in rates of obesity and sedentary lifestyles. A number of studies have shown that MetS is associated with a state of low-grade inflammation, characterized by abnormal pro-inflammatory cytokine production, increased acute-phase reactants, and activation of a network of inflammatory signalling pathways. Moreover, MetS has also been linked to oxidative stress, a consequence of a reduction in the antioxidant systems and an increase in the production of reactive oxygen species. Nevertheless, agreement exists that dietary intervention may modulate the pro-inflammatory state and lessen oxidative stress related to MetS, thereby decreasing the cardiovascular risk. In this review we address the current available evidence regarding dietary modulation of inflammation and oxidative stress associated with MetS.
    Full-text · Article · Oct 2013
Show more